Georgia Healthcare Group PLC Notice of Results (7518N)
August 11 2017 - 2:00AM
UK Regulatory
TIDMGHG
RNS Number : 7518N
Georgia Healthcare Group PLC
11 August 2017
London, 11 August 2017
Georgia Healthcare Group PLC notice of 2Q and 1H 2017
Results
Georgia Healthcare Group PLC ("GHG") will publish its financial
results for 2Q and 1H 2017 at 07:00 London time on Tuesday, 15
August 2017. The results announcement will be available on GHG's
website at ghg.com.ge. An investor/analyst conference call,
organised by GHG, will be held on Tuesday, 15 August 2017, at 14:00
UK / 15:00 CET / 09:00 U.S Eastern Time. The duration of the call
will be 60 minutes and will consist of a 15-minute update and a
45-minute Q&A session.
Dial-in numbers: 30-Day replay
Pass code for replays / conference Pass code for replays /
ID: 68385863 conference ID: 68385863
International Dial in: + 44 International Dial in:
(0) 2071 928000 +44 (0) 1452 55 00 00
UK: 08445718892 UK National Dial in: 08717000145
US: 16315107495 UK Local Dial in: 08443386600
Austria: 019286559 US Free Call Dial in: 1
(866) 247 4222
Belgium: 024009874
Czech Republic: 228881424
Denmark: 32728042
Finland: 0942450806
France: 0176700794
Germany: 030221531802
Hungary: 0614088064
Ireland: 014319615
Italy: 0687502026
Luxembourg: 27860515
Netherlands: 0207143545
Norway: 23960264
Spain: 914146280
Sweden: 0850692180
Switzerland: 0315800059
Name of authorised official of issuer responsible for making
notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding
company of the largest healthcare services provider in the
fast-growing, predominantly privately-owned, Georgian healthcare
services market. GHG's leadership position is underpinned by
offering the most comprehensive range of inpatient and outpatient
services targeting the mass market segment through its vertically
integrated network of 35 hospitals and ten ambulatory clusters
(consisting of 13 district ambulatory clinics and 28 express
ambulatory clinics), as at 31 March 2017. GHG is the single largest
market participant, accounting for 23.4% of total hospital bed
capacity in the country, as of 31 March 2017. From January 2017,
GHG become the largest pharmaceuticals retailer and wholesaler in
Georgia, with approximately 29% market share based on 31 December
2015 revenue figures. GHG is also the largest provider of medical
insurance in Georgia with a 35.3% market share based on net
insurance premiums earned and approximately 135,000 insurance
customers as at 31 March 2017. GHG employed a total of c.14,600
people as at 31 March 2017, including c.3,300 physicians.
For further information, please visit www.ghg.com.ge or
contact:
Nikoloz Gamkrelidze Irakli Gogia Ketevan Kalandarishvili
CEO CFO Head of Investor
Relations
+995 322 550505 +995 322 550505 +995 322 550505
(5077) (5088) (5079)
ngamkrelidze@ghg.com.ge irakligogia@ghg.com.ge ir@ghg.com.ge
This news report is presented for general informational purposes
only and should not be construed as an offer to sell or the
solicitation of an offer to buy any securities
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREFLBFDVFXBBQ
(END) Dow Jones Newswires
August 11, 2017 02:00 ET (06:00 GMT)
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Apr 2023 to Apr 2024